Cholangitis

Hispanic people with primary biliary cholangitis (PBC) are significantly less likely to achieve complete lab-based remission — defined as a normalization of the liver damage…

Use of the experimental immune-modulating therapy CNP-104 in adults with primary biliary cholangitis (PBC) participating in a U.S. clinical trial led to greater reductions in markers…

People with primary biliary cholangitis (PBC) who don’t start treatment after being diagnosed with the liver disease end up hospitalized more often and for…

Primary sclerosing cholangitis (PSC) patients with inflammatory bowel disease (IBD) face a higher risk of liver-related complications and the need for a liver transplant…

A noninvasive liver scan used alongside a standard blood test may accurately predict the severity of liver scarring, or fibrosis, in people with primary…

Receiving a liver transplant from a living donor is associated with an increased risk — as much as four times higher — of disease recurrence…

February is Rare Liver Diseases Month, and this year, the Global Liver Institute (GLI) is highlighting the importance of early diagnosis for better health…

People who are exposed to more sunlight over their lifetimes are less likely to develop primary biliary cholangitis (PBC), a study shows. “This suggests…

Researchers have identified three proteins that may be key targets for treating primary sclerosing cholangitis (PSC), and one of these proteins may also be…

Vitamin D was shown to ease the effects of liver inflammation and damage in primary biliary cholangitis (PBC), a chronic form of cholangitis,…